These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 24059690

  • 1. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.
    Redón J, Pascual-Izuel JM, Rodilla E, Vicente A, Oliván J, Bonet J, Torguet JP, Calaforra O, Almirall J.
    Blood Press; 2014 Jun; 23(3):181-8. PubMed ID: 24059690
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW.
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [Abstract] [Full Text] [Related]

  • 3. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y, Marc-Aurèle J, Bielmann P, Alaupovic P, Cartier P, Bichet D, Thibault G, Lupien PJ.
    Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study.
    Rosei EA, Rizzoni D, Comini S, Boari G, Nebivolol-Lisinopril Study Group.
    Blood Press Suppl; 2003 May; 1():30-5. PubMed ID: 12800985
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.
    Fogari R, Zoppi A, Lazzari P, Mugellini A, Lusardi P, Preti P, Van Nueten L, Vertommen C.
    J Hum Hypertens; 1997 Nov; 11(11):753-7. PubMed ID: 9416986
    [Abstract] [Full Text] [Related]

  • 6. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
    Tzemos N, Lim PO, MacDonald TM.
    Circulation; 2001 Jul 31; 104(5):511-4. PubMed ID: 11479245
    [Abstract] [Full Text] [Related]

  • 7. Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension.
    Simon G, Johnson ML.
    Clin Exp Hypertens; 1993 May 31; 15(3):501-9. PubMed ID: 8098243
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G.
    Blood Press Suppl; 2003 Dec 31; 2():35-40. PubMed ID: 14761075
    [Abstract] [Full Text] [Related]

  • 10. Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure.
    Eeftinck Schattenkerk DW, van den Bogaard B, Cammenga M, Westerhof BE, Stroes ES, van den Born BJ.
    J Hypertens; 2013 Dec 31; 31(12):2447-54. PubMed ID: 24126713
    [Abstract] [Full Text] [Related]

  • 11. A comparison of atenolol and nebivolol in isolated systolic hypertension.
    Dhakam Z, Yasmin, McEniery CM, Burton T, Brown MJ, Wilkinson IB.
    J Hypertens; 2008 Feb 31; 26(2):351-6. PubMed ID: 18192850
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
    Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH.
    Clin Exp Pharmacol Physiol; 2007 Apr 31; 34(4):327-31. PubMed ID: 17324145
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
    Tuncer M, Guntekin U, Gunes Y, Gumrukcuoglu HA, Eryonucu B.
    Adv Ther; 2008 Jun 31; 25(6):619-26. PubMed ID: 18563311
    [Abstract] [Full Text] [Related]

  • 15. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ, Stapff M, Lin Y.
    Am J Cardiovasc Drugs; 2013 Apr 31; 13(2):129-40. PubMed ID: 23519546
    [Abstract] [Full Text] [Related]

  • 16. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J, Barbosa L, Silva JA, Bertoquini S.
    Blood Press Monit; 2010 Oct 31; 15(5):235-9. PubMed ID: 20577082
    [Abstract] [Full Text] [Related]

  • 17. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress.
    Arosio E, De Marchi S, Prior M, Zannoni M, Lechi A.
    J Hypertens; 2002 Sep 31; 20(9):1793-7. PubMed ID: 12195121
    [Abstract] [Full Text] [Related]

  • 18. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.
    Nodari S, Metra M, Dei Cas L.
    Eur J Heart Fail; 2003 Oct 31; 5(5):621-7. PubMed ID: 14607201
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.